跳至主要内容
临床试验/NCT02801786
NCT02801786Unknown2 期

Randomized Study of the Use of Tamoxifen Versus Ointment Lidocaine for Reducing the Pain and Discomfort in Mammography

Universidade Federal de Goias1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2018年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
450
试验地点
1
主要终点
Tamoxifen for pain during mammography

研究概览

简要总结

This is a double-blind placebo-controlled randomized clinical trial to test the use of tamoxifen or lidocaine for diminishing the pain and discomfort while performing mammography, intending to include 450 patients distributed between the three groups.

详细描述

This is a double-blind placebo-controlled randomized clinical trial to test the use of tamoxifen or lidocaine for diminishing the pain and discomfort while performing mammography, intending to include 450 patients distributed between the three groups.

Inclusion criteria:Patients presenting mastalgia with a prior indication for mammography who is over 40 years old, undergoing their radiological examination at the university hospital of the Federal University of Goias. The only patients who were not included were those who did not wish to participate in the study.

The patients will receive:

  • Group 1:Five capsules containing 20mg of tamoxifen plus one sachet containing gel placebo;
  • Group 2: Five capsules containing placebo and one sachet containing lidocaine gel at 4%;
  • Group 3: Five capsules containing placebo plus one sachet containing gel placebo.

Mammography procedures: The mammography at the university hospital was carried out using a high-resolution mammograph with mean compression in each plane of approximately 800 newtons.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with mastalgia in the mastology program with age 40 who have indication for mammography.

排除标准

  • Patients who do not wish to participate in the study
  • Patients who underwent prosthetic silicone implants
  • Patients who mammoplasty (breast reduction or mastopexy) were submitted
  • Pregnant women
  • Patients allergic to tamoxifen or to lidocaine, heart disease, or patients with a history deep vein thrombosis.

研究组 & 干预措施

Placebo

Placebo Comparator

Five capsules containing placebo

干预措施: Placebo (Drug)

Tamoxifen

Experimental

Five capsules containing 20mg of tamoxifen.

干预措施: Placebo (Drug)

Tamoxifen

Experimental

Five capsules containing 20mg of tamoxifen.

干预措施: Tamoxifen (Drug)

Lidocaine

Experimental

One sachet containing lidocaine gel at 4%

干预措施: Placebo (Drug)

Lidocaine

Experimental

One sachet containing lidocaine gel at 4%

干预措施: Lidocaine (Drug)

结局指标

主要结局

Tamoxifen for pain during mammography

时间窗: Between review, test, randomization, application of results, data analysis and delivery of results for publication will be 24 months.

An additional 15% of patients who did not experience pain during mammography using the medication.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ruffo Freitas-Junior

Responsible Party was entered in the old format as Ruffo Freitas-Junior,Federal University of Goias.

Universidade Federal de Goias

研究点 (1)

Loading locations...

相似试验

TAmoxifen Versus LIdocaine Cream. A Randomized... | 临床试验